Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Clinical trial NCT04306367 · COMPLETED
Trial details
- NCT number
- NCT04306367
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2023-07-16
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.